Once fully operational, it will be the first U.K. hospital to provide 24/7 production of non-hazardous sterile compounds through a central intravenous additive service, according to a LinkedIn post by Lindsey Amerine, PharmD, chief pharmacy officer of Cleveland Clinic.
Calling this project “a huge milestone,” Dr. Amerine expressed pride in being part of the team driving the initiative.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.